亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯(lián)系方式|購物車
企業(yè)會員第1年

臺州保隆化工有限公司  

輪環(huán)藤寧 格拉替雷 4-甲氧基乙酰乙酸甲酯 胡椒乙酸 Boc-氨基酸 1,4,8,11-四氮雜環(huán)十四烷

搜索
新聞中心
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
  • 聯(lián)系人:周女士
  • 電話:0576-88702853
  • 郵件:amanda@bolonpharm.com
站內(nèi)搜索
 
榮譽資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產(chǎn)品 > 瑞替加濱****
瑞替加濱****
單價 面議對比
詢價 暫無
發(fā)貨 浙江臺州市付款后3天內(nèi)
過期 長期有效
更新 2015-09-29 17:06
 
詳細信息
 中文名稱:瑞替加濱**** 
英文名稱:Retigabine Dihydrochloride
英文別名:D 20443; Ethyl [2-amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]carbamate Dihydrochloride; N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic Acid Ethyl Ester Dihydrochloride; ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate dihydrochloride; ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate hydrochloride
CAS:150812-13-8
分子式:C16H19ClFN3O2
分子量:339.7924
©2025 臺州保隆化工有限公司 版權所有   技術支持:化工網(wǎng)   訪問量:13315  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |